Collagen I, III and IV content in airways and lung parenchyma of COPD patients
T. Mauad, R. Annoni, T. Lancas, S. Fernezlian, L. F. Silva, B. Andreina, S. Battaglia, M. Dolhnikoff, P. Hiemstra, P. Sterk, K. Rabe (Sao Paulo, Brazil; Palermo, Italy; Amsterdam, Netherlands)
Source: Annual Congress 2010 - Proteases and the matrix
Session: Proteases and the matrix
Session type: Thematic Poster Session
Number: 4371
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Mauad, R. Annoni, T. Lancas, S. Fernezlian, L. F. Silva, B. Andreina, S. Battaglia, M. Dolhnikoff, P. Hiemstra, P. Sterk, K. Rabe (Sao Paulo, Brazil; Palermo, Italy; Amsterdam, Netherlands). Collagen I, III and IV content in airways and lung parenchyma of COPD patients. Eur Respir J 2010; 36: Suppl. 54, 4371
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Collagen type III content in large airways and distal lung of fatal asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Type I and III collagen protein precursors in the airways of smokers and COPD-patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
The influence of roflumilast on the IV-type collagen level in patients with III stage COPD Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012
Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 171s Year: 2006
Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Changes in bronchial mucous membrane depending on the stage of COPD (I, II) Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Increased urotensin II in BALF and lung tissue in rat model of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant Source: International Congress 2017 – New insights into pathogenesis of lung disease Year: 2017
Transplant of alveolar type II cells restore pulmonary surfactant in lung fibrosis Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010
Effects of pulmonary rehabilitation on peripheral muscle fibre characteristics in COPD patients with gold stages II to IV Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation Year: 2009
A neo-epitope of collagen type VII (C7) is elevated in serum of patients with COPD and SSC Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
Respiratory function in stage II pulmonary sarcoidosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 385s Year: 2001
Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008
Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012
Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014
The dynamics of IV-type collagen contents in BALF of patients with COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
The role of cell lines in modelling the type II pneumocyte in interstitial lung disease Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease Year: 2020
TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005